News

Novo Nordisk anticipates launching Tresiba, brand name of insulin degludec, in the UK and Denmark during the first six months of 2013 and in other states all through

The only approved entirely human monoclonal antibody Ilaris continuously neutralizes interleukin-1 beta thereby inhibiting inflammation. Novartis division head David Epstein said, "When approved, lIaris will provide a new

Hidrox is an ingredient derived from olive polyphenols and the only formulation of organic hydroxytyrosol developed to reduce inflammation. CreAgri founder and CEO Roberto Crea said, "We’ve had

Hospitalized sickle cell disease patients experiencing vaso-occlusive crisis were examined for the efficacy, safety and pharmacokinetics of GMI-1070. The double-blinded study enrolled a total of 76 patients between

The approval was based on safety and efficacy data from two double-blind, randomized, multi-center trials conducted in adults whose OAB symptoms were not managed using anticholinergic treatments. Allergan

The study designed to assess the investigational drug AXL1717 in patients with relapsed or progressive malignant astrocytomas (glioblastoma and anaplastic astrocytoma) is conducted at the Rush University Medical

POD that facilitates a cleanroom space of 768ft² in addition to a partial ceiling height of 15′ is designed to preserve relative humidity at 35% in a controlled

The collaboration will focus on developing a system based on Quantum Cascade Laser (QCL) infrared spectroscopy for the noncontact cleaning verification of vessels throughout the manufacturing process. The

The new patent provides protection for the company’s universal flu vaccine target, M2e, which is a viral peptide common in all flu strains. Augmenta founder, president and CSO